Date Posted: Dec 17, 2018
Application Deadline: Open Until Filled
Dr. Michael Andreeff, Section of Molecular Hematology & Therapy, Department of Leukemia at the University of Texas MD Anderson Cancer Center invites applications for a postdoctoral position. We are looking for an innovative and motivated individual with technical expertise in cell and molecular biology to conduct a highly ambitious project for targeting drug-resistant leukemia stem cells.
Applicant will conduct research into the characterization of myeloid leukemia stem cells through a combinatorial study of genomic data, gene expression, and protein expression in leukemia cell subpopulations. The ultimate goal is the identification of novel susceptibility targets specifically in drug-resistant leukemia stem-like cells. Researcher will collaborate with established and committed investigators in an interdisciplinary research project that involves cell culture, cell sorting, mass cytometry, DNA/RNA sequencing and analysis, and NSG-S mouse models. Researcher will present scientific results in project meetings, national and international conferences, and in high impact scientific publications.
The ideal candidate is a recently graduated cell or molecular biologist PhD with practical experience and excellent knowledge-base in cell signaling and cell surface proteins, and with experience in at least one of the following areas of discipline: hematopoiesis/leukemia, molecular cloning, RNA and DNA sequencing, flow cytometry, and/or big data analysis. The applicant enjoys providing practical and theoretical training for students and promotes scientific collaboration within the research group, and will have excellent written and spoken (English) communication skills.
M. D. Anderson Cancer Center is an equal opportunity employer and does not discriminate on basis of race, color, national origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas M. D. Anderson Cancer Center are security sensitive and subject to examination of criminal history record information. Smoke-free and drug-free environment.